Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Department of Health and Human Services
NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms underlying a disorder or an intervention response. As part of NIMHs Clinical Trial Pipeline, this NOFO encourages early stage testing of pharmacologic interventions with novel mechanisms of actions or device-based interventions. More specifically, this NOFO is intended to support early stage testing of pharmacologic or device-based interventions using a protocol design where the presumed mechanism of action of the intervention is adequately tested, to provide meanin
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
11/26/2024
Closes
2027-10-15
Eligibility
Eligibility
Public and State controlled institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationState governmentsSpecial district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationIndependent school districtsNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesPrivate institutions of higher educationCity or township governmentsFor profit organizations other than small businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Small businessesCounty governmentsNative American tribal organizations (other than Federally recognized tribal governments)
Program
Funding area
Health - HL
Opportunity #
PAR-25-184
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov